Abbott - ABBVIE INC. - Affymax - Akebia Therapeutics - AM Pharma B.V - Amag Pharmaceuticals - Amgen - Amicus Therapeutics - Astrazeneca - AZD ESRD - Baxter Healthcare Corporation - BAYER - Bristol-Myers Squibb - Cubist Pharmaceuticals - Cytopherx - Fibrogen - Genzyme - Glaxo Smith Kline - Kadmon - Luitpold Pharmaceuticals - Mitsubishi - National Heart, Lung, and Blood Institute - NIH FHN - Nov Artis Pharmaceuticals - Novo Nordisk Pharmaceuticals - Omeros Corporation - Otsuka Pharmaceuticals - Pharmaceutical Product - Development - Pharmocosmo - Reata Pharmaceuticals - Relypsa -Retrophin - Roche - Rockwell Medical Technologies Cruise - Sandoz Inc. - Shire Regernerative Medicine Inc - St. Jude Medical -Takeda Pharmaceuticals - Theravacne Biopharma - Vascular Pharmaceuticals - Vifor International
Covance - Icon Clinical Research - IQVIA - PPD - Q2 Solutions - Quintiles - Trial Runner - Vennstrategies
Our clinical research program is streamlined to initiate studies on a timely basis. Our site works closely with UCLA IRB, UCLA Coverage Analysis, and UCLA Clinical Contracts teams to help expedite the start up of clinical trials. Our site has on-site basic equipment, including EKG,Hemo Cue machines, and more. Our site has full access to the UCLA pharmacy, local labs, clinical research patient rooms, and radiology services.
If you are interested in doing a study at UCLA or have any questions:
Contact (310) 954-2692 or email COREKidney@mednet.ucla.edu